Ocular Therapeutix
OCUL
OCUL
148 hedge funds and large institutions have $1.13B invested in Ocular Therapeutix in 2024 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 60 increasing their positions, 23 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
148
Holders Change
+30
Holders Change %
+25.42%
% of All Funds
2.15%
Holding in Top 10
8
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+166.67%
% of All Funds
0.12%
New
47
Increased
60
Reduced
23
Closed
16
Calls
$2.95M
Puts
$14.4M
Net Calls
-$11.4M
Net Calls Change
-$11.1M
Top Buyers
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$65.1M |
| 2 |
SR
Summer Road
West Palm Beach,
Florida
|
+$61M |
| 3 |
TCM
TCG Crossover Management
Palo Alto,
California
|
+$48.4M |
| 4 |
VA
VR Adviser
New York
|
+$45.4M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$31.8M |
Top Sellers
| 1 |
Franklin Resources
San Mateo,
California
|
-$21.2M |
| 2 |
Millennium Management
New York
|
-$5.51M |
| 3 |
SCM
Sio Capital Management
New York
|
-$5.35M |
| 4 |
BS
Banco Santander
Madrid,
Spain
|
-$3.02M |
| 5 |
D.E. Shaw & Co
New York
|
-$2.1M |
